SCHEMBL9769592

SCHEMBL9769592

CC(C)CCC[C@@H](C)[C@H]1C[C@H](O)[C@@]2(C)C3=CC[C@H]4C(C)(C)[C@@H](OC(=O)c5ccccc5)CC[C@]4(C)[C@H]3CC[C@]12C

nearest known ligand 0.54

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ HMGCR P04035 2/20 0.54
▸ PTPN1 P18031 2/20 0.47
▸ PTGES O14684 2/20 0.45
▸ NFKB1 P19838 8/20 0.41
▸ NFKB2 Q00653 8/20 0.41
▸ RELA Q04206 8/20 0.41
▸ ACLY P53396 1/20 0.40
▸ ACACA Q13085 1/20 0.40
▸ IKBKB O14920 2/20 0.39
▸ CETP P11597 2/20 0.39
▸ PTPN2 P17706 1/20 0.39
▸ NR1H4 Q96RI1 1/20 0.38
▸ HIF1A Q16665 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9769593 1.00 HMGCR (0.54) HMGCRPTPN1PTGESNFKB1NFKB2
SCHEMBL10698012 1.00 HMGCR (0.54) HMGCRPTPN1PTGESNFKB1NFKB2
SCHEMBL9769594 0.92 HMGCR (0.49) HMGCRPTPN1PTGESNFKB1NFKB2
SCHEMBL9769587 0.92 HMGCR (0.49) HMGCRPTPN1PTGESNFKB1NFKB2
SCHEMBL10698010 0.88 HMGCR (0.45) HMGCRPTPN1
SCHEMBL9769614 0.86 HMGCR (0.46) HMGCR
SCHEMBL9766813 0.84 HMGCR (0.53) HMGCRPTPN1PTGESNFKB1NFKB2
SCHEMBL9766817 0.84 HMGCR (0.53) HMGCRPTPN1PTGESNFKB1NFKB2
SCHEMBL9766823 0.84 HMGCR (0.52) HMGCRPTPN1PTGESNFKB1NFKB2
SCHEMBL9644097 0.83 HMGCR (0.51) HMGCRPTPN1PTGESNFKB1NFKB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5041432-A Enzyme inhibitors E. I. DU PONT DE NEMOURS AND COMPANY (US) 1991-08-20 — — US disclosed
US-5034548-A Enzyme inhibitors for reducing serum cholesterol E. I. DU PONT DE NEMOURS AND COMPANY (US) 1991-07-23 — — US disclosed
EP-0276823-A2 14,15-Substituted lanosterols and their use as hypocholesterolemic agents THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1988-08-03 — — EP disclosed
Send feedback